Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage.
Saved in:
| Title: | Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage. |
|---|---|
| Authors: | Labrenz J; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Edelmann D; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Kopp-Schneider A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Schlenk RF; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V and Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany. |
| Source: | Pharmaceutical statistics [Pharm Stat] 2023 Mar; Vol. 22 (2), pp. 236-247. Date of Electronic Publication: 2022 Oct 25. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101201192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-1612 (Electronic) Linking ISSN: 15391604 NLM ISO Abbreviation: Pharm Stat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36285348 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Labrenz+J%22">Labrenz J</searchLink>; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Edelmann+D%22">Edelmann D</searchLink>; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heitmann+JS%22">Heitmann JS</searchLink>; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Salih+HR%22">Salih HR</searchLink>; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kopp-Schneider+A%22">Kopp-Schneider A</searchLink>; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schlenk+RF%22">Schlenk RF</searchLink>; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V and Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101201192%22">Pharmaceutical statistics</searchLink> [Pharm Stat] 2023 Mar; Vol. 22 (2), pp. 236-247. <i>Date of Electronic Publication: </i>2022 Oct 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101201192 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1539-1612 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215391604%22">15391604 </searchLink><i>NLM ISO Abbreviation: </i>Pharm Stat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36285348 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/pst.2268 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 236 Titles: – TitleFull: Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Labrenz J – PersonEntity: Name: NameFull: Edelmann D – PersonEntity: Name: NameFull: Heitmann JS – PersonEntity: Name: NameFull: Salih HR – PersonEntity: Name: NameFull: Kopp-Schneider A – PersonEntity: Name: NameFull: Schlenk RF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2023 Mar Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1539-1612 Numbering: – Type: volume Value: 22 – Type: issue Value: 2 Titles: – TitleFull: Pharmaceutical statistics Type: main |
| ResultId | 1 |